Acadian Asset Management
CATX icon

Acadian Asset Management’s Perspective Therapeutics CATX Stock Holding History

Acadian Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,871
Closed -$38K – 1686
2024
Q3 		$38K Buy
+2,871
New +$38.2K ﹤0.01% 1874
2020
Q4 		– Sell
-5,323
Closed -$31K – 2207
2020
Q3 		$31K Hold
5,323
– – ﹤0.01% 1967
2020
Q2 		$30K Sell
5,323
-7,840
-60% -$50.4K ﹤0.01% 2039
2020
Q1 		$69K Buy
13,163
+11,611
+748% +$87.7K ﹤0.01% 1438
2019
Q4 		$10K Buy
+1,552
New +$6.81K ﹤0.01% 1755

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Acadian Asset Management's CATX Position: Q4 2024 in Review

Acadian Asset Management sold out of Perspective Therapeutics (CATX) in Q4 2024, closing a stake of 2,871 shares — an estimated $38K sold.

Acadian Asset Management first reported a position in CATX in Q4 2019 and held it in 5 quarters. The position peaked at $69K in Q1 2020. 135 funds tracked by Wall St. Rank hold CATX as of Q4 2024.

  • Acadian Asset Management reported no remaining Perspective Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 2,871 Perspective Therapeutics shares in Q4 2024, an estimated $38K.
  • Acadian Asset Management first reported a position in Perspective Therapeutics in Q4 2019 and held it in 5 quarters.
  • Acadian Asset Management's Perspective Therapeutics position peaked at $69K in Q1 2020.
  • 135 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.